Looking for spondyloarthritis in adults with sudden inflammation at the front of the eye
Studies how often spondyloarthritis occurs in adults with acute anterior uveitis.
Key facts
- Who runs it
- Marmara University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 15 Jan 2023
- Expected to end
- 15 Jan 2030
- Type of study
- Observational
- Record updated
- 6 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with uveitis, an inflammation inside the eye, seen at eye clinics. It studies how often they also have spondyloarthritis, an inflammatory joint and back disease.
- Age
- 18 Years to 75 Years
- Sex
- All
- Disease stage
- Uveitis. The study focuses on acute anterior uveitis, a sudden inflammation at the front of the eye.
- Biomarker or test result
- Both HLA-B27-positive and HLA-B27-negative people are studied.
Main reasons for not taking part
- Spondyloarthritis diagnosed before the uveitis attack
- Uveitis caused by an infection
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- patients with uveitis
Who cannot take part
- patients diagnosed spondyloarthiritis before from the uveitis attack
- patients with infectious uveitis
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Spondyloarthritis (SpA) encompasses a group of inflammatory rheumatic diseases characterized by axial and/or peripheral arthritis, along with extra-articular manifestations such as enthesitis, dactylitis, uveitis, and skin lesions. Axial spondyloarthritis (axSpA), the hallmark of which is chronic sacroiliitis, can progress to vertebral fusion ("bamboo spine") in advanced cases. The prevalence of axSpA varies globally, ranging from 0.1% to 1.4%, with a higher incidence in men and a typical onset in the second or third decades of life. Diagnostic approaches include imaging techniques such as sacroiliac MRI and radiographs, alongside clinical criteria like inflammatory back pain, NSAID responsiveness, peripheral arthritis, and HLA-B27 positivity. Disease management primarily involves NSAIDs, with biologics used for refractory cases, and disease activity is monitored using indices such as BASDAI and ASDAS.
Read full original descriptionShow less
Acute anterior uveitis (AAU) is the most common extra-articular manifestation of SpA, particularly associated with HLA-B27 positivity. It often presents unilaterally with redness, pain, and photophobia but can lead to severe complications if inadequately treated. Around 50% of patients with HLA-B27-positive AAU have underlying SpA, and the prevalence of uveitis increases with longer disease duration. While the link between SpA and AAU is well-established, further research is needed to determine optimal systemic treatment and follow-up protocols. This study aims to assess the prevalence and clinical characteristics of SpA in patients presenting with AAU at ophthalmology clinics.
The group in the trial
- main cohort
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Spondyloarthritis in an Acute Anterior Uveitis Inception Cohort: a Cross Sectional and Prospective Comparative Study of HLA-B27-positive and -negative Cases
- Plain-language title
- Looking for spondyloarthritis in adults with sudden inflammation at the front of the eyeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06720376, who can take part
- Record updated
- 6 December 2024